Mass tort is the highest-value lead category in legal marketing — and among the most misunderstood. A qualified AFFF claimant can be worth $50,000–$300,000 in attorney fees. An Ozempic gastroparesis case is worth $40,000–$150,000. That case value justifies lead costs that would be unsustainable for standard PI.
This guide covers the active dockets in 2026, what's driving volume in each, and how to build a lead generation funnel that produces qualified claimants at scale.
Why Mass Tort Lead Generation Is Different
Mass tort lead generation is categorically different from standard PI lead gen in three ways:
- Qualifying criteria are specific and rigid. A general MVA lead just needs injury + insurance + no rep. An AFFF lead needs confirmed exposure at a military base or airport, a specific cancer diagnosis, and a timeframe. Pre-screening is not optional — it's the entire value of the lead.
- The audience doesn't know they have a case. A car accident victim knows they need a lawyer within hours. A retired firefighter who developed bladder cancer may have no idea that AFFF foam exposure is the cause — or that there's a national MDL waiting for them. Awareness-first marketing is critical.
- Case values and CPL scale together. You can justify $500–$2,000 per qualified mass tort claimant when the case is worth $50,000+. The economics are completely different from standard PI, and the competition reflects this.
Active Mass Tort Dockets in 2026
AFFF (Aqueous Film-Forming Foam) — Firefighting Foam Cancer
AFFF is a firefighting foam used extensively at military bases and civilian airports for decades. It contains PFAS ("forever chemicals") linked to kidney cancer, testicular cancer, bladder cancer, and thyroid cancer. The MDL is one of the largest active dockets in federal court. Target: military veterans, civilian airport firefighters, and people who lived near military installations with AFFF training. Typical case value: $75,000–$300,000+.
Ozempic / Wegovy (GLP-1 Drugs) — Gastroparesis
GLP-1 receptor agonists (Ozempic, Wegovy, Mounjaro, Rybelsus) have been linked to severe gastroparesis — a condition where the stomach cannot empty properly — requiring hospitalization in serious cases. Target: people who took these drugs for diabetes or weight loss and experienced severe nausea, vomiting, stomach pain, or gastroparesis diagnosis. Growing docket with significant pending claims. Typical case value: $40,000–$150,000.
Paraquat — Parkinson's Disease
Paraquat is a widely used agricultural herbicide linked to a 2–5x increased risk of Parkinson's disease with chronic exposure. Target: agricultural workers, farm owners, pesticide applicators, and people who lived near farms with regular paraquat use. The MDL has been active for several years with significant claimant volume. Typical case value: $100,000–$250,000.
Camp Lejeune Water Contamination
Marines, families, and civilian workers stationed at Camp Lejeune (1953–1987) were exposed to contaminated drinking water linked to leukemia, bladder cancer, kidney cancer, and non-Hodgkin's lymphoma. The 2022 PACT Act opened claims. Target: veterans and family members who lived/worked at Camp Lejeune during the exposure period with a qualifying diagnosis. Still active claimant volume despite the docket's age.
Hair Relaxer (Chemical) — Uterine Cancer
Chemical hair relaxers have been linked to a significantly elevated risk of uterine cancer and uterine fibroids. An NIH study published in 2022 was the catalyst for litigation. Target: women who used chemical hair relaxers over a sustained period and developed uterine cancer or required hysterectomy for fibroids. Strong docket with significant pending claims. Typical case value: $50,000–$200,000.
NEC Baby Formula (Premature Infants)
Cow's milk-based infant formula from Abbott (Similac) and Mead Johnson (Enfamil) has been linked to necrotizing enterocolitis (NEC), a life-threatening intestinal condition, in premature infants. Target: parents of premature babies born before 2022 who were fed these formulas in the NICU and developed NEC. High emotional value case with significant verdict potential.
Mass Tort Lead Generation: Channel Strategy
Facebook and Instagram — The Primary Channel
Meta ads are the dominant channel for mass tort lead generation because the audience doesn't know they have a case. Search intent doesn't exist for someone who doesn't know their cancer was caused by their military job. Facebook/Instagram allows you to reach these audiences by demographic, interest, veteran status, and life event targeting.
What works on Meta for mass tort:
- Awareness-first copy: "Did you serve at a military base before 2005?" performs better than "File your AFFF lawsuit now." The first creates discovery; the second assumes awareness that doesn't exist.
- Video ads: 30–60 second explainer videos outperform static images for mass tort by 2–3x. The potential claimant needs context before they'll take action.
- Tight audience targeting: Veterans, agricultural workers, women with uterine conditions, GLP-1 drug users. Meta's interest and behavioral targeting is more powerful for mass tort than any other channel.
Google Search — For High-Awareness Dockets
For dockets that have received significant media coverage (AFFF, Camp Lejeune, Ozempic), Google search volume is now substantial. Keywords like "AFFF lawsuit," "Ozempic lawsuit," and "Camp Lejeune claim" generate real search volume from claimants who've seen news coverage and are now looking for legal help.
| Docket | Top Keywords | Avg. CPC | Lead Quality |
|---|---|---|---|
| AFFF | "AFFF lawsuit", "firefighting foam cancer" | $25–$60 | Very High |
| Ozempic | "Ozempic lawsuit", "Ozempic gastroparesis" | $30–$75 | High |
| Paraquat | "Paraquat Parkinson's lawsuit" | $20–$50 | High |
| Camp Lejeune | "Camp Lejeune water claim" | $15–$40 | Very High |
| Hair Relaxer | "hair relaxer cancer lawsuit" | $20–$45 | High |
What Makes a Qualified Mass Tort Lead
Mass tort pre-screening is far more rigorous than standard PI. A qualified lead must meet specific criteria — and a lead that fails any criterion is worthless. The pre-screening questions vary by docket, but generally confirm:
- Exposure: Was the potential claimant exposed to the relevant substance? (AFFF at military base, paraquat on farm, hair relaxer consistently for 5+ years)
- Diagnosis: Does the potential claimant have a qualifying medical diagnosis? (specific cancer type, gastroparesis, Parkinson's, NEC for a child)
- Timeframe: Did the exposure occur during the qualifying window for the docket?
- No prior representation: Have they already retained an attorney for this claim?
- Statute of limitations: Is the claim still within the filing window?
AI pre-screening for mass tort: Legal Leadz AI's AI qualification engine screens mass tort claimants against docket-specific criteria before delivering the lead. Our mass tort leads include exposure confirmation, diagnosis verification, and representation status — the three criteria that most commonly generate bad leads when left unscreened.
Mass Tort Lead Cost: What to Expect
| Docket | CPL Range (Qualified) | Typical Case Value | ROI Multiple (per signed case) |
|---|---|---|---|
| AFFF | $400–$900 | $75K–$300K+ | 100–500x |
| Ozempic/GLP-1 | $300–$700 | $40K–$150K | 60–300x |
| Paraquat | $350–$750 | $100K–$250K | 130–450x |
| Camp Lejeune | $200–$500 | $100K–$400K | 200–1,000x |
| Hair Relaxer | $250–$600 | $50K–$200K | 80–600x |
The ROI multiples look extraordinary because they are — mass tort is the reason large PI firms grow to nine figures. The key is qualification. A $600 unqualified mass tort lead is a waste. A $600 qualified lead that signs and recovers $200,000 is a 333x return on the lead cost alone.
Compliance: What You Cannot Do in Mass Tort Marketing
Mass tort advertising is heavily scrutinized by state bars, the FTC, and plaintiff firm competitors. These are the hard compliance lines:
- Never guarantee outcomes or settlement amounts. No "average settlements of $X" in ads — this is attorney advertising misconduct in most states.
- No attorney-client relationship is formed by the ad or intake form. Your landing page disclaimer must make clear that submitting a form does not create representation.
- Attorney supervision required. Lead generation for mass tort must be connected to an actual law firm — non-attorney companies cannot "sign" clients in most states.
- State bar advertising rules apply. Every state has specific rules about comparative claims, testimonials, and certification claims in legal advertising.
Interested in Mass Tort Leads?
Legal Leadz AI generates pre-screened mass tort claimants for AFFF, Ozempic, Paraquat, and other active dockets. Get a free consultation to discuss your target docket, qualification criteria, and estimated CPL.
Talk to Us About Mass Tort →